• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

避孕阴道环:综述。

Contraceptive vaginal rings: a review.

机构信息

PROFAMILIA, P.O. Box 1053, Santo Domingo 10401, Dominican Republic.

出版信息

Contraception. 2010 Nov;82(5):418-27. doi: 10.1016/j.contraception.2010.04.012. Epub 2010 May 20.

DOI:10.1016/j.contraception.2010.04.012
PMID:20933115
Abstract

Development efforts on contraceptive vaginal rings were initiated over 40 years ago based on two principles: the capacity of the vaginal epithelium to absorb steroids and the capacity of elastomers to release these hormones at a nearly constant rate. Numerous models of contraceptive vaginal rings (CVRs) have been studied, but only two have reached the market: NuvaRing, a combined ring that releases etonogestrel (ENG) and ethinylestradiol (EE), and Progering, a progesterone-releasing ring for use in lactating women. The main advantages of CVRs are their effectiveness (similar to or slightly better than the pill), ease of use without the need of remembering a daily routine, user's ability to control initiation and discontinuation, nearly constant release rate allowing for lower doses, greater bioavailability and good cycle control with the combined ring. The main disadvantages are related to the mode of delivery; CVRs may cause vaginal discharge and complaints, ring expulsion is not uncommon, the ring may be felt during coitus and vaginal insertion may be unpleasant for some women. The studies reviewed in this article provide evidence that CVRs are safe, effective and highly acceptable to women. There is no doubt that CVRs offer a new, effective contraceptive option to women, expanding their available choices of hormonal contraception.

摘要

避孕阴道环的研发工作始于 40 多年前,其基于两个原理:阴道上皮吸收甾体激素的能力和弹性体以近乎恒定的速率释放这些激素的能力。已经研究了许多避孕阴道环(CVR)模型,但只有两种进入市场:NuvaRing,一种释放依托孕烯(ENG)和乙炔雌二醇(EE)的组合环,以及 Progering,一种用于哺乳期妇女的孕激素释放环。CVR 的主要优点是其有效性(与药丸相似或略好)、无需记住日常使用的便利性、使用者能够控制开始和停止使用的能力、允许使用较低剂量的近乎恒定释放率、更高的生物利用度和联合环的良好周期控制。主要缺点与输送方式有关;CVR 可能会导致阴道分泌物和不适,环脱落并不少见,在性行为期间可能会感觉到环,并且阴道插入对某些女性来说可能不愉快。本文综述的研究提供了证据表明 CVR 是安全、有效和高度被女性接受的。毫无疑问,CVR 为女性提供了一种新的、有效的避孕选择,扩大了她们可选择的激素避孕方法。

相似文献

1
Contraceptive vaginal rings: a review.避孕阴道环:综述。
Contraception. 2010 Nov;82(5):418-27. doi: 10.1016/j.contraception.2010.04.012. Epub 2010 May 20.
2
Current status of contraceptive vaginal rings.避孕阴道环的现状。
Contraception. 2013 Mar;87(3):264-72. doi: 10.1016/j.contraception.2012.08.037. Epub 2012 Oct 4.
3
Contraceptive vaginal rings.避孕阴道环
Semin Reprod Med. 2001 Dec;19(4):381-90. doi: 10.1055/s-2001-18646.
4
The contraceptive vaginal ring.避孕阴道环。
Semin Reprod Med. 2010 Mar;28(2):133-9. doi: 10.1055/s-0030-1248138. Epub 2010 Mar 29.
5
The vaginal contraceptive pill.阴道避孕药丸。
IPPF Med Bull. 1985 Feb;19(1):2-3.
6
Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.释放诺孕酮和炔雌醇的避孕阴道环:一项为期1年的剂量探索试验。
Contraception. 2005 Feb;71(2):122-9. doi: 10.1016/j.contraception.2004.08.010.
7
Vaginal ring contraception.阴道环避孕。
Contraception. 2011 Feb;83(2):107-15. doi: 10.1016/j.contraception.2010.07.008. Epub 2010 Oct 6.
8
Depo Provera. Position paper on clinical use, effectiveness and side effects.醋酸甲羟孕酮避孕针。关于临床应用、疗效及副作用的立场文件。
Br J Fam Plann. 1999 Jul;25(2):69-76.
9
The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.复方避孕阴道环(努瓦环)与卫生棉条同时使用。
Contraception. 2004 Mar;69(3):197-9. doi: 10.1016/j.contraception.2003.10.014.
10
High acceptability and satisfaction with NuvaRing use.对使用NuvaRing(阴道环)具有高度可接受性和满意度。
Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 2:31-6; discussion 37-9.

引用本文的文献

1
Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy.下一代 3D 打印多功能预防阴道环,用于预防 HIV、HSV-2 和非意愿性怀孕。
J Control Release. 2024 Dec;376:1209-1224. doi: 10.1016/j.jconrel.2024.10.059. Epub 2024 Nov 12.
2
Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice.局部给药的纳米混悬液可增加雌二醇的递送量,用于治疗小鼠阴道萎缩。
Drug Deliv Transl Res. 2025 Feb;15(2):609-620. doi: 10.1007/s13346-024-01618-6. Epub 2024 May 15.
3
Comparison of Combined Parenteral and Oral Hormonal Contraceptives: A Systematic Review and Meta-Analysis of Randomized Trials.
胃肠外与口服激素避孕药的比较:随机试验的系统评价与荟萃分析
J Clin Med. 2024 Jan 19;13(2):575. doi: 10.3390/jcm13020575.
4
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability.在一项1期临床试验中,参与者使用用于预防艾滋病毒和怀孕的多功能阴道环的体验:从使用者身上学习以提高可接受性。
Front Reprod Health. 2023 Jul 6;5:1147628. doi: 10.3389/frph.2023.1147628. eCollection 2023.
5
Application of Sol-Gels for Treatment of Gynaecological Conditions-Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery.溶胶-凝胶在妇科疾病治疗中的应用——生理视角与阴道内药物递送的新兴概念
Gels. 2022 Feb 8;8(2):99. doi: 10.3390/gels8020099.
6
Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis.临床研究中避孕阴道环的可接受性与满意度:一项系统评价与叙述性综合分析
Front Glob Womens Health. 2021 Dec 14;2:799963. doi: 10.3389/fgwh.2021.799963. eCollection 2021.
7
The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings.阴道微生物群、细菌生物膜与聚合物药物释放阴道环
Pharmaceutics. 2021 May 19;13(5):751. doi: 10.3390/pharmaceutics13050751.
8
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators.月经周期和炔雌醇/依托孕烯避孕阴道环对颗粒溶素和其他黏膜免疫介质的影响。
Am J Reprod Immunol. 2021 Aug;86(2):e13412. doi: 10.1111/aji.13412. Epub 2021 Mar 16.
9
Design and Characterization of a Novel Series of Geometrically Complex Intravaginal Rings with Digital Light Synthesis.基于数字光合成技术的新型系列几何复杂阴道环的设计与表征
Adv Mater Technol. 2020 Aug;5(8). doi: 10.1002/admt.202000261. Epub 2020 Jun 23.
10
MATRIX-BASED CONTROLLED RELEASE DELIVERY OF ACYCLOVIR FROM POLY-(ETHYLENE CO-VINYL ACETATE) RINGS.基于基质的阿昔洛韦从聚(乙烯-醋酸乙烯酯)环中的控释递送
J Drug Deliv Sci Technol. 2020 Feb;55. doi: 10.1016/j.jddst.2019.101391. Epub 2019 Nov 13.